← Every applicant
Ischemaview, Inc. FDA Approvals
0 new drug approvals and 17 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| Rapid Platform (R6.7)510(k)Sep 21, 2026Radiology |
| Rapid Aortic Measurements510(k)Sep 23, 2025Radiology |
| Rapid Obstructive Hydrocephalus, Rapid OH510(k)Sep 4, 2025Radiology |
| Rapid DeltaFuse510(k)Aug 26, 2025Radiology |
| Rapid MLS510(k)May 28, 2025Radiology |
| Rapid Neuro3D510(k)Jan 22, 2025Radiology |
| Rapid510(k)Apr 22, 2024Radiology |
| Rapid ASPECTS (v3)510(k)Jan 19, 2024Radiology |
| Rapid (6.0)510(k)Jan 16, 2024Radiology |
| Rapid SDH510(k)Oct 25, 2023Radiology |
| Rapid Aneurysm Triage and Notification510(k)Jul 27, 2023Radiology |
| Rapid NCCT Stroke510(k)Mar 2, 2023Radiology |
| Rapid RV/LV510(k)Feb 1, 2023Radiology |
| Rapid ICH510(k)Sep 12, 2022Radiology |
| Rapid LVO510(k)May 31, 2022Radiology |
| Rapid PE Triage and Notification (PETN)510(k)May 17, 2022Radiology |
| Rapid510(k)Feb 8, 2022Radiology |